We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Surgery to Repair Myelin in MS Patient

By HospiMedica staff writers
Posted on 05 Apr 2002
In a groundbreaking clinical trial, surgeons have transplanted cells from the ankle into the brain of two multiple sclerosis (MS) patients in an effort to repair myelin, the protective brain and spinal cord sheath that is destroyed by MS. More...
The trial is taking place at the Yale School of Medicine (New Haven, CT, USA; www.yale.edu).

Animal studies show that Schwann cells can replace the cells that generate myelin. So the Yale surgeons harvested Schwann cells from the patient's ankle and injected them into the patient's brain, which had lesions. The patient is then monitored for six months by neuroimaging and other tests. After six months, a small biopsy will be taken to determine whether the cells survived and whether they made any myelin. Two patients have undergone the procedure and three more are scheduled to participate.

"The patient is doing fine,” said Timothy Vollmer, M.D., associate professor of neurology at Yale, referring to the second patient who had the procedure. "He has a high level of disability because of the locations of the lesions in the brain, but he is otherwise healthy.”




Related Links:
Yale

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.